A detailed history of Mountain Pacific Investment Advisers Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 139,279 shares of CRL stock, worth $27 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares
139,279
Previous 142,082 1.97%
Holding current value
$27 Million
Previous $29.4 Million 6.52%
% of portfolio
1.93%
Previous 2.22%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$187.96 - $245.29 $526,851 - $687,547
-2,803 Reduced 1.97%
139,279 $27.4 Million
Q2 2024

Jul 10, 2024

SELL
$206.39 - $268.73 $380,170 - $495,000
-1,842 Reduced 1.28%
142,082 $29.4 Million
Q1 2024

Apr 11, 2024

BUY
$203.52 - $273.43 $207,590 - $278,898
1,020 Added 0.71%
143,924 $39 Million
Q4 2023

Feb 02, 2024

BUY
$164.52 - $238.84 $1.6 Million - $2.32 Million
9,723 Added 7.3%
142,904 $33.8 Million
Q3 2023

Oct 20, 2023

BUY
$194.44 - $217.61 $1.72 Million - $1.92 Million
8,821 Added 7.09%
133,181 $26.1 Million
Q2 2023

Jul 26, 2023

BUY
$183.71 - $210.25 $2.71 Million - $3.11 Million
14,775 Added 13.48%
124,360 $26.1 Million
Q1 2023

May 23, 2023

BUY
$191.89 - $259.92 $482,411 - $653,438
2,514 Added 2.35%
109,585 $22.1 Million
Q4 2022

Jan 20, 2023

BUY
$197.11 - $250.07 $3.38 Million - $4.29 Million
17,170 Added 19.1%
107,071 $0
Q3 2022

Oct 13, 2022

BUY
$182.44 - $250.54 $2.93 Million - $4.02 Million
16,056 Added 21.74%
89,901 $17.7 Million
Q2 2022

Jul 21, 2022

BUY
$204.13 - $302.4 $45,316 - $67,132
222 Added 0.3%
73,845 $15.8 Million
Q1 2022

Apr 19, 2022

BUY
$255.51 - $362.11 $245,034 - $347,263
959 Added 1.32%
73,623 $20.9 Million
Q4 2021

Jan 19, 2022

BUY
$351.38 - $448.68 $632,132 - $807,175
1,799 Added 2.54%
72,664 $27.4 Million
Q3 2021

Oct 25, 2021

BUY
$372.64 - $458.3 $4,471 - $5,499
12 Added 0.02%
70,865 $29.2 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $48,538 - $61,322
165 Added 0.23%
70,853 $26.2 Million
Q1 2021

Apr 14, 2021

BUY
$249.67 - $299.48 $1.26 Million - $1.52 Million
5,060 Added 7.71%
70,688 $20.5 Million
Q4 2020

Jan 21, 2021

BUY
$222.0 - $252.62 $77,922 - $88,669
351 Added 0.54%
65,628 $16.4 Million
Q3 2020

Oct 13, 2020

BUY
$175.56 - $226.45 $9,655 - $12,454
55 Added 0.08%
65,277 $14.8 Million
Q2 2020

Jul 09, 2020

BUY
$118.84 - $189.72 $6.81 Million - $10.9 Million
57,312 Added 724.55%
65,222 $11.4 Million
Q1 2020

Apr 08, 2020

BUY
$98.9 - $178.34 $120,855 - $217,931
1,222 Added 18.27%
7,910 $998,000
Q4 2019

Jan 21, 2020

SELL
$126.05 - $152.76 $70,461 - $85,392
-559 Reduced 7.71%
6,688 $1.02 Million
Q3 2019

Oct 15, 2019

SELL
$125.07 - $143.67 $750 - $862
-6 Reduced 0.08%
7,247 $959,000
Q2 2019

Jul 23, 2019

SELL
$123.4 - $148.55 $5,553 - $6,684
-45 Reduced 0.62%
7,253 $1.03 Million
Q1 2019

May 07, 2019

BUY
$104.82 - $146.73 $12,578 - $17,607
120 Added 1.67%
7,298 $1.06 Million
Q4 2018

Jan 25, 2019

BUY
$105.09 - $137.23 $311,486 - $406,749
2,964 Added 70.34%
7,178 $812,000
Q2 2018

Jul 25, 2018

BUY
$102.37 - $117.25 $431,387 - $494,091
4,214 New
4,214 $473,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.